Galmed Pharmaceuticals Ltd. (GPH.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 2.17M |
| Enterprise Value | -9.55M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.17 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.28 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.84 |
| 52-Week Change 3 | -92.29% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 4.8600 |
| 52 Week Low 3 | 0.2620 |
| 50-Day Moving Average 3 | 0.3299 |
| 200-Day Moving Average 3 | 0.4340 |
Share Statistics
| Avg Vol (3 month) 3 | 1.68k |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 6.01M |
| Implied Shares Outstanding 6 | 6.65M |
| Float 8 | 5.78M |
| % Held by Insiders 1 | 3.87% |
| % Held by Institutions 1 | 6.20% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | May 15, 2023 |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -28.22% |
| Return on Equity (ttm) | -50.63% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.46M |
| Net Income Avi to Common (ttm) | -6.91M |
| Diluted EPS (ttm) | -2.3300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.64M |
| Total Cash Per Share (mrq) | 2.1 |
| Total Debt (mrq) | 41k |
| Total Debt/Equity (mrq) | 0.29% |
| Current Ratio (mrq) | 4.81 |
| Book Value Per Share (mrq) | 2.75 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6.14M |
| Levered Free Cash Flow (ttm) | -3.63M |
© 2024 Yahoo. All rights reserved.